Study shows disparities in buprenorphine and extended-release naltrexone filled prescriptions during the pandemic.

A study published in JAMA Network Open shows that the COVID-19 pandemic was associated with an immediate decrease in prescriptions filled for buprenorphine by members of racial and ethnic minority groups. Per authors, Thuy Nguyen, PhD, et al., the findings suggest that members of these minority groups suffered larger losses in access to buprenorphine from July 2019 to March 2022.

Read the study

Read an article published in Rutgers Today

Get the latest updates in your inbox!